Redefining Injectables.
One Layer at a Time.

16 October, 2025

Nanexa named as finalist in Fierce Innovation Awards Life Sciences Edition 2025

Nanexa, is pleased to announce that the company has been selected as a finalist in the Drug Delivery Technology category by the renowned industry publication Fierce Life Sciences. The annual Fierce Life Sciences Innovation Awards identify and showcase outstanding innovation that is driving improvements in life science technologies. Their panel of expert judges has identified Nanexa as a company whose pioneering solutions have the potential to create efficiencies, engage patients, or revolutionize the pharmaceutical industry.

1 October, 2025

Nanexa AB changes Certified Adviser to Tapper Partners AB

Nanexa AB announces today that the company is changing its Certified Adviser to Tapper Partners AB.

27 August, 2025

Nanexa publishes interim report for January-June 2025

Download attachment

6 May, 2025

Nanexa publishes interim report for January-March 2025

Download attachment